Suboxone settlement boosts Dr. Reddy’s Q1 net
Proceeds from a settlement pact with British drugmaker lndivior and its strategy of divesting brands to sharpen focus on core products aided pharma major Dr. Reddy’s Laboratories in reporting manifold increase in consolidated net profit to ₹1,189 crore for the first quarter. Besides contributing to the sharp rise from ₹380.4 crore of the year-earlier period, […]
Continue Reading